Regional and conditional variability of FXR: new lessons on ileal inflammation and gut barrier functions
Authors:
- 1 November 2024
- journal article
- editorial
- Published by American Physiological Society in American Journal of Physiology-Gastrointestinal and Liver Physiology
- Vol. 327 (5) , G626-G628
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- FXR deletion attenuates intestinal barrier dysfunction in murine acute intestinal inflammationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2024
- Bile acids, bioactive signalling molecules in interoceptive gut‐to‐brain communicationThe Journal of Physiology, 2022
- The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate ImmunityCells, 2021
- Ablation of liver Fxr results in an increased colonic mucus barrier in miceJHEP Reports, 2021
- Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X ReceptorEBioMedicine, 2020
- Bile acid metabolites control TH17 and Treg cell differentiationNature, 2019
- Activation of the Nuclear Receptor Fxr Improves Intestinal Cell Tolerance to Ischemia–Reperfusion InjuryShock, 2018
- Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel diseaseGut, 2011
- Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptorProceedings of the National Academy of Sciences, 2006
- Targeted Disruption of the Nuclear Receptor FXR/BAR Impairs Bile Acid and Lipid HomeostasisCell, 2000